RenovoRx Statistics

Total Valuation

RenovoRx has a market cap or net worth of $42.56 million. The enterprise value is $30.38 million.

Market Cap	42.56M
Enterprise Value	30.38M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026, after market close.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

RenovoRx has 45.10 million shares outstanding. The number of shares has increased by 40.21% in one year.

Current Share Class	45.10M
Shares Outstanding	45.10M
Shares Change (YoY)	+40.21%
Shares Change (QoQ)	+3.75%
Owned by Insiders (%)	3.38%
Owned by Institutions (%)	10.82%
Float	39.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.58
Forward PS	8.69
PB Ratio	3.77
P/TBV Ratio	3.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	20.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.02.

Current Ratio	7.15
Quick Ratio	6.58
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -100.47% and return on invested capital (ROIC) is -62.12%.

Return on Equity (ROE)	-100.47%
Return on Assets (ROA)	-51.58%
Return on Invested Capital (ROIC)	-62.12%
Return on Capital Employed (ROCE)	-102.70%
Weighted Average Cost of Capital (WACC)	9.72%
Revenue Per Employee	$87,588
Profits Per Employee	-$721,706
Employee Count	17
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.62% in the last 52 weeks. The beta is 1.00, so RenovoRx's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-31.62%
50-Day Moving Average	0.89
200-Day Moving Average	0.98
Relative Strength Index (RSI)	56.47
Average Volume (20 Days)	290,290

Short Selling Information

The latest short interest is 416,166, so 0.92% of the outstanding shares have been sold short.

Short Interest	416,166
Short Previous Month	384,039
Short % of Shares Out	0.92%
Short % of Float	1.04%
Short Ratio (days to cover)	1.38

Income Statement

In the last 12 months, RenovoRx had revenue of $1.49 million and -$12.27 million in losses. Loss per share was -$0.33.

Revenue	1.49M
Gross Profit	1.17M
Operating Income	-12.37M
Pretax Income	-12.27M
Net Income	-12.27M
EBITDA	-12.37M
EBIT	-12.37M
Loss Per Share	-$0.33

Full Income Statement

Balance Sheet

The company has $12.36 million in cash and $186,000 in debt, giving a net cash position of $12.18 million or $0.27 per share.

Cash & Cash Equivalents	12.36M
Total Debt	186,000
Net Cash	12.18M
Net Cash Per Share	$0.27
Equity (Book Value)	11.27M
Book Value Per Share	0.25
Working Capital	11.80M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.30M
Capital Expenditures	n/a
Depreciation & Amortization	2,000
Net Borrowing	n/a
Free Cash Flow	-11.30M
FCF Per Share	-$0.25

Full Cash Flow Statement

Margins

Gross Margin	78.71%
Operating Margin	-830.69%
Pretax Margin	-823.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.21%
Shareholder Yield	-40.21%
Earnings Yield	-28.83%
FCF Yield	-26.55%

Analyst Forecast

The average price target for RenovoRx is $7.03, which is 644.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.03
Price Target Difference	644.94%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	224.13%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RenovoRx has an Altman Z-Score of 0.5 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.5
Piotroski F-Score	3